NCT03844113View on ClinicalTrials.gov

Carnosine for Peripheral Vascular Disease

PHASE2UnknownINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Carnosine

Each participant will be given a daily oral dose 2 g of carnosine for 6 months

DRUG

Placebo

Each participant will be given a daily oral dose 2 g of methycellulose powder for 6 months

Trial Locations (1)

3168

RECRUITING

Monash Centre for Health Research and Implementation, Melbourne

Sponsors

Collaborators (1)

Monash Health
All Listed Sponsors
collaborator

Monash Health

OTHER

lead

Monash University

OTHER

NCT03844113 - Carnosine for Peripheral Vascular Disease | Biotech Hunter | Biotech Hunter